 Co-founder of Life Science Angels (www.lifescienceangels.org), the largest and most well-known early-stage investment group in the U.S. focused solely on emerging, medical device, diagnostic, biotech and mobile health companies (LSA) In 2014, LSA was named the Top Angel Investment Group in the United States by industry analytical source CB Insights (https://www.cbinsights.com/blog/top-angel-groups-mosaic/) To date, LSA has invested and its affiliates have invested over $55M in 60 companies, with over $800M in follow-on capital, and had 19 positive exits

Advancing precision medicine by commercializing proprietary tests and data analytics based on signaling pathways to optimize therapeutic decisions

FundamentalVR are market leaders in surgical AR/VR technology. The combination of its haptics, multi-user capabilities, sophisticated use cases and applications will allow the company to dominate U.S. surgical training as it is uniquely positioned to provide the proficiency tools and metrics needed to lower the learning curve for trainee and qualified surgeons. The combination of massive economic dislocation and social distancing brought on by COVID-19 are driving permanent change in surgical training and testing as well as the marketing and adoption of new medical devices.

Woodside Medical Management (WMM) is an incubator focused on helping US based medical device and diagnostics companies commercialize their products in China. We have partnered with an incubator in Suzhou (InnoVentures) and a large animal study/CRO company (Gateway Medical), and have 6 projects in various stages.

I have been a co-Founder, Chairman, CEO or Investor in over 100 medical device, biotech and diagnostics companies. Current board memberships include Celero Systems, Zeto Medical, Perceptive Ablation, Woodside Wireless, Noctrix, and Indevor Corp.

 Joined with cardiologist and inventor Thomas Fogarty to establish a $70M venture capital fund focused on medical devices and healthcare Invested in 30 companies and had 18 positive exits